Availability of blood components and plasma derived medicines in Iran.
نویسنده
چکیده
Iran is a country with advanced health care system. In 1974 government of Iran established a centralized transfusion system. Since then donations of blood may not be remunerated and therapy with blood and its components is free of charge for all Iranian patients in need of the treatment. Most of donors in Iran are educated middle age men. In 2005 Iranian donated more than 1.6 millions units of blood. Although Iran population has doubled in past three decades blood donation has increased several folds. Donations are meticulously screened through interviewing of donors and lab testing of the donations using serological methods. In contrary to blood and blood components, Iran is heavily depends on importation of plasma derived medicines. Irrational use of blood components and low surveillance on use of plasma derived medicines, which are highly subsidized by the government, is a major challenge in transfusion medicines in Iran.
منابع مشابه
Implementation of Plasma Fractionation in Biological Medicines Production
Context: The major motivation for the preparation of the plasma derived biological medicine was the treatment of casualties from the Second World War. Due to the high expenses for preparation of plasma derived products, achievement of self-sufficiency in human plasma biotechnological industry is an important goal for developing countries.Evidence Acquisition: The complexity of the bloo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
دوره 37 1 شماره
صفحات -
تاریخ انتشار 2007